Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 588 (LINC00588) is a human long non-coding RNA (lncRNA) gene, which does not encode a protein but may play regulatory roles in gene expression[1][3][7]. Alternative names include C8orf71 and DKFZP434F122. LINC00588 has been identified as differentially expressed in several cancer studies and is being investigated as a potential non-invasive biomarker for the diagnosis of lung cancer and as a tumor suppressor in osteosaroma, where it is proposed to act as a competitive endogenous RNA (ceRNA) regulating microRNA activity[2][5]. However, there are currently no direct therapeutic drugs targeting LINC00588 and its mechanistic details remain under-characterized in the scientific literature. LINC00588 is not a protein, receptor, enzyme, or transporter, but belongs to the class of long intergenic non-coding RNAs, classified simply as "Other" in molecular function[1][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 588 (LINC00588).